Calamos Advisors’s Braskem BAK Stock Holding History

Calamos Advisors’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-106,600	Closed	-$2.26M	–	619
2016 Q4	$2.26M	Buy	+106,600	New	+$1.88M	0.02%	486

Other funds holding BAK

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Calamos Advisors's BAK Position: Q1 2017 in Review

Calamos Advisors sold out of Braskem (BAK) in Q1 2017, closing a stake of 106,600 shares — an estimated $2.26M sold.

Calamos Advisors first reported a position in BAK in Q4 2016 and held it in 1 quarter. The position peaked at $2.26M in Q4 2016. 83 funds tracked by Wall St. Rank hold BAK as of Q1 2017.

Calamos Advisors reported no remaining Braskem position as of Q1 2017 after selling out during the quarter.
Calamos Advisors sold 106,600 Braskem shares in Q1 2017, an estimated $2.26M.
Calamos Advisors first reported a position in Braskem in Q4 2016 and held it in 1 quarter.
Calamos Advisors's Braskem position peaked at $2.26M in Q4 2016.
83 funds tracked by Wall St. Rank held Braskem as of Q1 2017.

Based on Calamos Advisors's 13F filing for Q1 2017, filed 20 Apr 2017.